New diabetes drugs show fewer negative effects
Two experimental once daily pills in a new drug class could boost older diabetes therapies by lowering blood sugar and offering slight weight loss. Merck and Novartis seek FDA approval to market Januvia and Galvus by year end at a projected 3 to 6 dollars per day, higher than current medicines.
MENTIONED IN THIS ARTICLE
Washington
Merck & Co
Novartis AG
Tion
John Buse
The
ADA
Buse
Iraqi girl in L A nose reconstruction by UCLA doctors
A 12 year old Iraqi girl Marwa Naim had part of her nose damaged by a 2003 Baghdad missile strike. She recovered in California after free nose reconstruction at UCLA Medical Center, thanked the surgeons during a hospital visit while wearing a light green burqa.
MENTIONED IN THIS ARTICLE
Los Angeles
Marwa Naim
Iraq
Naim
Baghdad
California
Ucla Medical Center
Timothy Miller
Former FDA chief reveals Plan B over the counter plan
Former FDA commissioner Lester Crawford testified that the agency intended to allow over the counter sales of Plan B last year but delayed the move while defining age restrictions. He said the Aug 26 2005 announcement aimed to set enforcement rules for OTC sales to women 17 and older, with 16 and under requiring a prescription.
MENTIONED IN THIS ARTICLE
FDA
Washington
Food and Drug Administration
Lester Crawford
Crawford
Center For Reproductive Rights
Also Mentioned on This Page
Associated Press
International Diabetes Federation
American Diabetes Association
L.A
Nick Atiap
Black Gold Casino
Dad
Black Gold
Hobbs
West
Millen Drive
Lea County
Zia-Park
Blackgoldcasino.net
New Mexico
Garish Navax
M.D. OB/Gyn
Fawiy
East University
Market Place
Karen Perry
C.M.A
Mepicat Spa
Bolarean
Argon
Windowworldinc
S. CO. RD
Midland
Odessa
Levi's Signature Jeans
Pode
Tommy Hilfiger
Adidas
Reebok
Hanes & Fruit of the
Docker
Young Men's
Tee
Echo & Gunit
Claiborne
Perry Ellis
Burke's Outlet